irritable bowel syndrome
Tryp Therapeutics is seeking approval from U.S. regulators for a clinical trial on psilocybin-assisted therapy to help those with irritable bowel syndrome (IBS).
May 26, 2023
Minnesota state officials announced on Wednesday that the health department will add IBS and OCD to the list of qualifying medical conditions for participation in the state’s medical cannabis program.
December 1, 2022